JEEP timeline
Every JEEP batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| JEEP-2608-Y4367 | Hexarelin | 27 Aug 2026 | 2026-Q3 | 2 | 99.50 | 0.11 | 99.90 | +0.40 | |
| JEEP-2607-X3911 | Semaglutide | 12 Jul 2026 | 2026-Q3 | 6 | 99.18 | 1.42 | 99.63 | +0.45 | |
| JEEP-2605-M4874 | TB-500 | 31 May 2026 | 2026-Q3 | 8 | 99.82 | 0.52 | 99.90 | +0.08 | SHARED BULK |
| JEEP-2604-R3923 | Melanotan II | 13 Apr 2026 | 2026-Q2 | 5 | 99.57 | 0.72 | 99.90 | +0.33 | |
| JEEP-2603-E3844 | Cagrilintide | 27 Mar 2026 | 2026-Q2 | 2 | 99.54 | 0.14 | 99.61 | +0.07 | |
| JEEP-2603-G4602 | PT-141 (Bremelanotide) | 22 Mar 2026 | 2026-Q2 | 2 | 99.52 | 0.47 | 99.90 | +0.38 | |
| JEEP-2602-T3807 | Thymulin | 27 Feb 2026 | 2026-Q1 | 1 | 99.14 | n<2 | 99.84 | +0.70 | |
| JEEP-2602-J2798 | Tirzepatide | 22 Feb 2026 | 2026-Q2 | 6 | 98.93 | 1.15 | 99.33 | +0.40 | |
| JEEP-2602-R4187 | CJC-1295 with DAC | 19 Feb 2026 | 2026-Q2 | 3 | 99.00 | 0.59 | 99.62 | +0.62 | |
| JEEP-2602-V3434 | TB-500 | 18 Feb 2026 | 2026-Q3 | 6 | 99.73 | 0.43 | 99.90 | +0.17 | |
| JEEP-2602-C3015 | Semax | 08 Feb 2026 | 2026-Q1 | 3 | 99.08 | 0.56 | 99.90 | +0.82 | |
| JEEP-2601-K3139 | ARA-290 | 23 Jan 2026 | 2026-Q2 | 8 | 99.02 | 1.13 | 99.81 | +0.79 | |
| JEEP-2601-V2811 | CJC-1295 with DAC | 20 Jan 2026 | 2026-Q1 | 7 | 99.44 | 1.37 | 99.74 | +0.30 | |
| JEEP-2601-K3015 | PT-141 (Bremelanotide) | 07 Jan 2026 | 2026-Q2 | 8 | 99.45 | 0.86 | 99.64 | +0.19 | |
| JEEP-2512-U3413 | Semax | 20 Dec 2025 | 2026-Q1 | 2 | 99.68 | 0.50 | 99.90 | +0.22 | |
| JEEP-2511-V2580 | BPC-157 | 19 Nov 2025 | 2025-Q4 | 3 | 99.73 | 1.18 | 99.90 | +0.17 | |
| JEEP-2511-B3061 | SS-31 (Elamipretide) | 02 Nov 2025 | 2025-Q4 | 10 | 99.32 | 1.34 | 99.82 | +0.50 | |
| JEEP-2510-S3920 | L-Glutathione (reduced) | 23 Oct 2025 | 2026-Q1 | 5 | 99.08 | 0.61 | 99.90 | +0.82 | |
| JEEP-2510-K4647 | IGF-1 LR3 | 17 Oct 2025 | 2025-Q4 | 2 | 98.14 | 0.99 | 98.50 | +0.36 | |
| JEEP-2510-R4058 | TB-500 | 08 Oct 2025 | 2026-Q1 | 7 | 99.82 | 0.76 | 99.79 | -0.03 | |
| JEEP-2510-M4682 | IGF-1 DES (1-3) | 02 Oct 2025 | 2025-Q4 | 3 | 99.75 | 0.09 | 99.56 | -0.19 | |
| JEEP-2510-W2963 | Retatrutide | 01 Oct 2025 | 2025-Q4 | 3 | 99.07 | 0.64 | 99.03 | -0.04 | |
| JEEP-2509-G3860 | BPC-157 | 22 Sep 2025 | 2026-Q1 | 9 | 99.65 | 0.94 | 99.90 | +0.25 | |
| JEEP-2509-P2811 | CJC-1295 with DAC | 09 Sep 2025 | 2025-Q4 | 2 | 99.08 | 0.86 | 99.87 | +0.79 | |
| JEEP-2508-S3268 | GHRP-2 | 17 Aug 2025 | 2025-Q4 | 4 | 99.63 | 0.55 | 99.90 | +0.27 | |
| JEEP-2507-U3035 | N-Acetyl Semax Amide | 27 Jul 2025 | 2025-Q4 | 12 | 99.93 | 0.27 | 99.90 | -0.03 | |
| JEEP-2507-W2442 | MOTS-c | 13 Jul 2025 | 2025-Q3 | 8 | 99.67 | 1.19 | 99.90 | +0.23 | |
| JEEP-2507-B3026 | Pinealon | 11 Jul 2025 | 2025-Q4 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| JEEP-2507-V4206 | BPC-157 | 06 Jul 2025 | 2025-Q3 | 13 | 99.50 | 1.14 | 99.82 | +0.32 | |
| JEEP-2506-R3035 | BPC-157 | 17 Jun 2025 | 2025-Q3 | 7 | 99.14 | 1.04 | 99.90 | +0.76 | |
| JEEP-2505-J3812 | BPC-157 | 31 May 2025 | 2025-Q4 | 7 | 99.87 | 0.78 | 99.90 | +0.03 | |
| JEEP-2504-X2669 | BPC-157 | 01 Apr 2025 | 2025-Q3 | 4 | 98.15 | 0.53 | 99.17 | +1.02 | |
| JEEP-2503-B3455 | GHRP-6 | 03 Mar 2025 | 2025-Q2 | 5 | 99.57 | 0.65 | 99.90 | +0.33 | |
| JEEP-2502-J3559 | Epitalon | 11 Feb 2025 | 2025-Q2 | 2 | 99.93 | 0.00 | 99.90 | -0.03 | |
| JEEP-2412-U3223 | Tirzepatide | 31 Dec 2024 | 2025-Q2 | 16 | 99.10 | 1.31 | 99.61 | +0.51 | |
| JEEP-2412-M4106 | 5-Amino-1MQ | 20 Dec 2024 | 2025-Q2 | 2 | 99.73 | 0.41 | 99.90 | +0.17 | |
| JEEP-2412-N4458 | Tirzepatide | 07 Dec 2024 | 2025-Q1 | 7 | 99.48 | 1.02 | 99.77 | +0.29 | |
| JEEP-2411-B3841 | Liraglutide | 29 Nov 2024 | 2025-Q2 | 12 | 99.48 | 1.10 | 99.57 | +0.09 | |
| JEEP-2411-F3745 | Retatrutide | 10 Nov 2024 | 2024-Q4 | 6 | 97.98 | 1.02 | 98.85 | +0.87 | |
| JEEP-2410-C3420 | KPV | 30 Oct 2024 | 2025-Q1 | 2 | 99.77 | 0.33 | 99.90 | +0.13 | |
| JEEP-2408-V4075 | TB-500 | 11 Aug 2024 | 2024-Q4 | 2 | 99.77 | 0.33 | 99.90 | +0.13 | |
| JEEP-2408-K3061 | Leuprolide | 04 Aug 2024 | 2024-Q4 | 9 | 99.06 | 1.49 | 99.90 | +0.84 | |
| JEEP-2407-K3892 | TB-500 | 09 Jul 2024 | 2024-Q4 | 3 | 98.86 | 0.58 | 99.61 | +0.75 | |
| JEEP-2406-M4461 | MK-677 (Ibutamoren mesylate) | 25 Jun 2024 | 2024-Q4 | 13 | 99.60 | 0.85 | 99.90 | +0.30 | |
| JEEP-2405-A3970 | GHRP-2 | 20 May 2024 | 2024-Q4 | 1 | 98.46 | n<2 | 99.90 | +1.44 | |
| JEEP-2405-D3060 | Semaglutide | 18 May 2024 | 2024-Q4 | 17 | 99.00 | 1.79 | 99.65 | +0.65 | |
| JEEP-2403-V4264 | Semaglutide | 26 Mar 2024 | 2024-Q3 | 7 | 99.61 | 1.06 | 99.80 | +0.19 | |
| JEEP-2403-M2917 | SS-31 (Elamipretide) | 06 Mar 2024 | 2024-Q2 | 1 | 99.72 | n<2 | 99.90 | +0.18 | |
| JEEP-2401-R2856 | Semaglutide | 23 Jan 2024 | 2024-Q2 | 6 | 99.42 | 0.52 | 99.66 | +0.24 | |
| JEEP-2308-J3560 | Semaglutide | 28 Aug 2023 | 2024-Q1 | 3 | 98.87 | 0.84 | 99.74 | +0.87 |